C. Lima
3 Papers
2 Citations
C. Lima is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
Christina L. Roland,Elise F Nassif Haddad,Emily Z. Keung,Wei-Lien Wang,Alexander J. Lazar,Heather Lin,Manoj Chelvanambi,Edwin R Parra,Khalida Wani,B. Ashleigh Guadagnolo,Andrew J. Bishop,Elizabeth M. Burton,Kelly K. Hunt,Keila E. Torres,Barry W. Feig,Christopher P. Scally,Valerae O. Lewis,Justin E. Bird,Ravin Ratan,Dejka M. Araujo,M. A. Zarzour,Shreyaskumar Patel,Robert S. Benjamin,Anthony P. Conley,K. Livingston,Vinod Ravi,Hussein Abdul-Hassan Tawbi,Patrick P Lin,Bryan S. Moon,Robert L. Satcher,Bilal Mujtaba,Russell Witt,Raymond S Traweek,B. Cope,Rossana Lazcano,Chia-Chin Wu,Xiao Zhou,Mohammad M Mohammad,Randy A. Chu,Jianhua Zhang,Ashish V. Damania,Pranoti Sahasrabhojane,Taylor Tate,Kate Callahan,Sa Nguyen,Davis R. Ingram,Rohini R. Morey,Shadarra Crosby,Grace Mathew,Sheila Duncan,C. Lima,Jean-Yves Blay,Wolf H Fridman,Kenna R. Mills Shaw,Ignacio Wistuba,Andrew P Futreal,Nadim A. Ajami,J. Wargo,Neeta Somaiah +58 more
TL;DR: It is demonstrated that neoadjuvant ICB is associated with complex immune changes within the tumor microenvironment in DDLPS and UPS and that neoadjuvant ICB with concurrent radiotherapy has significant efficacy in UPS.
9
Abstract P4-08-19: Biomarker analysis: Multi-omics elucidation of Cohort 1 from a phase II study of a triple combination of Atezolizumab + cobimetinib + eribulin in patients with metastatic inflammatory breast cancer
Bora Lim,Angela Alexander,Jie Willey,Huiming Sun,Suyu Liu,Anisha B. Patel,Edwin R. Parra,Cara Haymaker,Luisa Solis Soto,Alejandra Serrano,Bao-Hua Sun,C. Lima,Auriole Tamegnon,Renganayaki Pandurengan,Dzifa Y. Douse,Jessica Lan,Luthra Raja,Randy A. Chu,Mark Knafl,Scott E. Woodman,Haifeng Zhu,K. S. Shulze,Katherine M. Fedenko,Walter C. Darbonne,Naoto Ueno,Vicente Valero +25 more
TL;DR: Lim et al. as mentioned in this paper showed that Az+Co may enhance the efficacy of chemotherapy in metastatic inflammatory breast cancer (mIBC) with a comprehensive multi-omics biomarker assessment.
2
Abstract 5305: Delta-like ligand 3 immunohistochemical expression landscape in high-grade lung neuroendocrine tumors
C. Lima,P. S. Rocha,Junya Fujimoto,Allison C. Stewart,Robert J. Cardnell,Wei Lu,Khaja B Khan,Beate Sable,Aaron R. Ellison,Ignacio I. Wistuba,C. Gay,Neda Kalhor,Lauren Averett Byers,Luisa M. Solis-Soto +13 more
TL;DR: It is confirmed that most high-grade lung neuroendocrine tumors express DLL3 across histology types and TNM stage, and suggest that a large subset of patients with high- grade lung neuro endocrine tumors may be a target population of interest for D LL3-targeted therapies.
1